News
ADAM10 regulates angiogenic events in human retinal microvascular endothelial cells (HRMVECs). Credit: The American Journal of Pathology (2025). DOI: 10.1016/j.ajpath.2025.03.007 ...
The authors of this study stated that even though ADAM10 and ADAM17 function at different phases of SARS-CoV-2 infection, both proteases function via proteolytic priming of the S protein.
New research has found that the endothelial cell-specific A disintegrin and metalloproteinase domain-containing protein 10 (ADAM10) regulates abnormal blood vessel growth in the damaged retina ...
A local study discovered a novel therapeutic target named ADAM10 that could be used to treat patients with Diabetic Retinopathy (DR), a condition which leads to blindness induced by prolonged ...
Hosted on MSN1mon
Targeting ADAM10 may offer hope for retinal disease treatment
While investigating how ADAM10 influences abnormal blood vessel growth, the researchers found that ADAM10 regulates the levels of the protein Ephrin B2 in endothelial cells, and decreasing Ephrin ...
Philadelphia, June 24, 2025 – New research has found that the endothelial cell-specific A disintegrin and metalloproteinase domain-containing protein 10 (ADAM10) regulates abnormal blood vessel ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results